Metastatic renal cell carcinoma, Curr Treat Options in Oncol, vol.4, pp.385-90, 2003. ,
Metastatic Behavior in Melanoma: Timing, Pattern, Survival, and Influencing Factors, J Oncol, 2012. ,
Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study, Lancet Oncol, vol.15, pp.387-95, 2014. ,
Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial, JAMA, vol.316, pp.401-410, 2016. ,
The linear-quadratic formula and progress in fractionated radiotherapy, Br J Radiol, vol.62, pp.679-94, 1989. ,
The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study, Int J Radiat Oncol Biol Phys, vol.12, pp.867-72, 1986. ,
Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts, Cancer, vol.80, pp.2519-2547, 1997. ,
The impact of radiosurgery fractionation and tumor radiobiology on the local control of brain metastases, J Neurosurg, vol.119, pp.1131-1139, 2013. ,
The biological advantage of single-session radiosurgery, J Neurosurg, vol.119, 2013. ,
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1), Eur J Cancer Oxf Engl, vol.45, pp.228-275, 1990. ,
State of the art on dose prescription, reporting and recording in intensity-modulated radiation therapy ,
, Cancer Radiother J Soc Francaise Radiother Oncol, vol.15, pp.555-564, 2011.
A simple dose gradient measurement tool to complement the conformity index, J Neurosurg, vol.105, pp.194-201, 2006. ,
The central role of the propensity score in observational studies for causal effects, Biometrika, vol.70, pp.41-55, 1983. ,
Model-based direct adjustment, J Am Stat Assoc, vol.82, pp.387-94, 1987. ,
Drawing Survival Curves using "ggplot2, 2017. ,
R: A language and environment for statistical computing, 2013. ,
Stereotactic radiosurgery for the treatment of melanoma and renal cell carcinoma brain metastases, Oncol Rep, vol.29, pp.407-419, 2013. ,
Outcomes following Hypofractionated stereotactic radiotherapy in the Management of Brain Metastases, Am J Clin Oncol, vol.39, pp.379-83, 2016. ,
Impact of stereotactic radiosurgery dose on control of cerebral metastases from renal cell carcinoma, Anticancer Res, vol.35, pp.3571-3575, 2015. ,
Control of brain metastases from radioresistant tumors treated by stereotactic radiosurgery, J Neuro-Oncol, vol.124, pp.507-521, 2015. ,
Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases, J Neurosurg, vol.123, pp.1261-1268, 2015. ,
Radiosurgery in the management of brain metastasis: a retrospective singlecenter study comparing gamma knife and LINAC treatment, J Neurosurg, vol.128, issue.2, pp.352-61, 2018. ,
Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome, J Neurosurg, vol.129, pp.50-59, 2018. ,
Single-fraction versus multifraction (3 × 9 Gy) stereotactic radiosurgery for large (>2 cm) brain metastases: a comparative analysis of local control and risk of radiation-induced brain necrosis, Int J Radiat Oncol Biol Phys, vol.95, pp.1142-1150, 2016. ,
The tumor radiobiology of SRS and SBRT: are more than the 5 Rs involved?, Int J Radiat Oncol Biol Phys, vol.88, pp.254-62, 2014. ,
A hypothesis: indirect cell death in the radiosurgery era, Int J Radiat Oncol Biol Phys, vol.91, pp.11-14, 2015. ,
The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery, Semin Radiat Oncol, vol.18, pp.240-243, 2008. ,
Tumor response to radiotherapy regulated by endothelial cell apoptosis, Science, vol.300, pp.1155-1164, 2003. ,
Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody, Clin Cancer Res Off J Am Assoc Cancer Res, vol.15, pp.5379-88, 2009. ,
Role of local radiation therapy in Cancer immunotherapy, JAMA Oncol, vol.1, pp.1325-1357, 2015. ,
Immunotherapy for renal cell carcinoma, Clin Dev Immunol, p.284581, 2010. ,
Awakening the immune system with radiation: optimal dose and fractionation, Cancer Lett, vol.368, pp.185-90, 2015. ,
Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes, Int J Radiat Oncol Biol Phys, vol.88, pp.986-97, 2014. ,
Interval from imaging to treatment delivery in the radiation surgery age: how long is too long?, Int J Radiat Oncol Biol Phys, vol.93, pp.126-158, 2015. ,
Stereotactic radiotherapy following surgery for brain metastasis: predictive factors for local control and radionecrosis, Cancer Radiother J Soc Francaise Radiother Oncol, vol.21, pp.4-9, 2017. ,
Fractionated stereotactic radiosurgery for patients with brain metastases, J Neuro-Oncol, vol.117, pp.295-301, 2014. ,
Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases, J Neuro-Oncol, vol.125, pp.149-56, 2015. ,